Skip to main content

Journal article Published 2021

Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro

Authors

A. Ledererova, Lucie Dostálová, V. Kozlova, H. Peschelova, A. Ladungova, M. Culen, T. Loja, J. Verner, S. Pospisilova, M. Smida, V. Mancikova

Journal for Immunotherapy of Cancer 9(8), e002352 (2021)

Cite this publication

LEDEREROVA, A., L. DOSTÁLOVÁ, V. KOZLOVA, H. PESCHELOVA, A. LADUNGOVA, M. CULEN, T. LOJA, J. VERNER, S. POSPISILOVA, M. SMIDA, V. MANCIKOVA: Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro. Journal for Immunotherapy of Cancer. 2021, 9(8), e002352, ISSN: 2051-1426, PMID: 34413165.

Details

ISSN
2051-1426

Authors from EATRIS